David Ricks, Eli Lilly CEO (David Paul Morris/Bloomberg via Getty Images)
Eli Lilly promises five new approvals in next two years with Alzheimer’s at the forefront
Eli Lilly set an ambitious goal before its investor day on Wednesday, promising to have new five approved drugs in the next two years. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
